Chinese scientists discover gene associated with prostate cancer
The research reveals that PCSEAT is overexpressed in prostate cancer patients, indicating that PCSEAT may be a potential therapeutic target
Beijing: Chinese scientists have identified a new gene strongly associated with prostate cancer, offering new methods for diagnosis and treatment of the disease. The newly identified biomarker, PCSEAT, was discovered by scientists from Suzhou Institute of Biomedical Engineering and Technology, state-run Xinhua news agency reported.
The research reveals that PCSEAT is overexpressed in prostate cancer patients, indicating that PCSEAT may be a potential therapeutic target. The research was published in the journal Biochemical and Biophysical Research Communications in May.
Based on the research, they have developed an early diagnosis for prostate cancer and applied for a patent. The application can significantly improve the accuracy of prostate cancer diagnosis and reduce the cost of diagnosis and treatment. China has seen increasing cases of prostate cancer in recent years.
- Zika virus may be present in other parts of India too: study
- Polio vaccine contamination: India to send team to Indonesia on 22 October
- Exploring the mystery of invasion by ballooning
- Three science podcasts to watch out for
- Post-Ockhi, scientists working on new model for better prediction of intensity of cyclones
- Govt liberalizes CBSE affiliation norms, says reforms will bring in more transparency
- Supreme Court’s decision on Aadhaar: impact on tax compliance
- Opinion | Crimes against women going unpunished
- Govt moots quarterly performance appraisal of top educational institutions
- Railways on the right track in states with JV projects
- India’s rising steel demand is making companies starry-eyed
- ACC’s operating margins feel the stress as cost pressures grow
- Federal Bank rides out Kerala floods but growth metrics need to sustain
- RIL’s consumer businesses deliver on growth; investments stay high
- Hero MotoCorp Q2: Costs apply brakes on profit growth